Home LiteratureArticle Details
PMID: 15292905 Published · ppublish English Journal Article

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

Cohen C, Perrault G, Griebel G, Soubrié P

Abstract

Conditioned stimuli are important for nicotine dependence and may trigger craving and relapse after prolonged nicotine abstinence. However, little is known about the pharmacology of this process. Among the systems that have been shown to play a role in drug-seeking behavior is the endocannabinoid transmission. Therefore, the present study examined the resistance to extinction of drug-seeking behavior elicited by nicotine-associated environmental stimuli and the effects of the selective CB1 cannabinoid antagonist rimonabant (SR141716) on the reinforcing effects of nicotine-related stimuli. Rats were trained to self-administer nicotine (0.03 mg/kg/injection, i.v.) under conditions in which responding was reinforced jointly by response-contingent nicotine injections and stimuli (light and tone). After self-administration acquisition, nicotine was withdrawn and lever pressing was only reinforced by contingent presentation of the audiovisual stimuli. Under such a condition, responding persisted for 3 months, following which nonpresentation of the cues produced a progressive extinction of responding. As expected, rats trained to lever-press for saline injections paired with the audiovisual stimuli did not acquire the self-administration. These findings indicate that the cues required learned association with nicotine to acquire reinforcing properties and to function as conditioned reinforcers. When administered 1 month following nicotine withdrawal, rimonabant (1 mg/kg, i.p.) decreased conditioned behavior. These results showing the persistence of a nicotine-conditioned behavior are congruent with the role of nicotine-related environmental stimuli in nicotine craving in abstinent smokers. Rimonabant, which has been shown previously to reduce nicotine self-administration, may be effective not only as an aid for smoking cessation but also in the maintenance of abstinence.

MeSH Terms
Acoustic Stimulation Animals Cues Dopamine/physiology Environment Extinction, Psychological/drug effects Light Male Motivation Motor Activity/drug effects Nicotine/pharmacology Nicotinic Agonists/pharmacology Piperidines/pharmacology Pyrazoles/pharmacology Rats Rats, Sprague-Dawley Receptor, Cannabinoid, CB1/antagonists & inhibitors Rimonabant Self Administration Substance Withdrawal Syndrome/psychology Synaptic Transmission/drug effects Tobacco Use Disorder/psychology
Chemicals
Nicotinic Agonists Piperidines Pyrazoles Receptor, Cannabinoid, CB1 Nicotine Rimonabant Dopamine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Cohen Caroline
Sanofi-synthelabo Recherche, Bagneux, France. Caroline.cohen@sanofi-synthelabo.com
Perrault Ghislaine
Griebel Guy
Soubrié Philippe
Article Info
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Abbr.
Neuropsychopharmacology
ISSN
0893-133X
Published
2005-01-00
Pages
145-55
Language
English
Region
England
NLM ID
8904907
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com